@hubermanlab

“PEPTIDE SOURCES & SAFETY • - My guest on the Huberman Lab podcast out now is Dr Abud Bakri, MD @abud_bakri We discuss peptides: BPC, GLPs (incl Retatrutide), GHK-Cu, Pinealon, Epitalon, TB500 and Thymosin, and more. The topic of sourcing came up and broadly speaking there are four categories: 1) Pharma (brand name): highest stringency, with respect to purity. 2) Compounding Pharmacies: here, there’s a huge range of quality, purity, and cost. There are some excellent compounding pharmacies out there. We discussed the more reputable ones on the podcast. This source still requires a prescription. 3) Gray Market: compounds being sold without prescription labeled “for research purposes only, not for animal or human use”. The range of quality and purity is vast. 4) Black market: not *necessarily* “home grown” but zero validation about what you’re taking. In theory, this is also a problem with certain gray market sources, but even more extreme with black market sources. The episode gets into the fact that for some peptides— in particular the GLPs/Reta there are randomized controlled trials to support their specific uses, (also true for Melanotan and GH secretagouges) but many people are taking these compounds for things other than what they were studied and approved for. (Off label use of FDA compounds is not on unusual but typically it’s a doctor making those decisions not the patient). For anyone who is peptide curious, skeptical, or anti-peptides (that are not studied with randomized control trials) as well as people who are very pro peptides will benefit from listening to the episode. You can find it at hubermanlab.com & on all podcast platforms. Thank you for your interest in science! @stanford @stanford.med”

Claim 1 (GLP-1 RAs / Retinoids) is strongly supported by human RCT evidence, including active Phase 3 trials. Claim 2 (Melanotan and GH secretagogues with RCT support) finds no clinical trial evidence and should be rated no_evidence. Claim 3 (BPC-157 for post-exercise injury) is supported by consistent preclinical data (animal models) and aligns with documented healing mechanisms, though human trials are lacking. Overall, the peptide claims range from well-supported (GLP-1) to preclinically sound but clinically unvalidated (BPC-157) to unsupported by trial data (Melanotan/GH secretagogues).

“Comment HUNGER & I’ll DM you a link to the full episode. MILD SLEEP LOSS IMPACTS MEN’S VS WOMEN’S HORMONES & HUNGER DIFFERENTLY • - My guest on the Huberman Lab podcast out now is Dr. Marie-Pierre St-Onge, PhD⁠, professor of nutritional medicine at Columbia University School of Medicine @columbiamed and an expert on the bidirectional relationship between nutrition and sleep. We discuss how even moderate sleep loss increases appetite, changes hunger-related hormones, and causes weight gain, even when calories are not increased. We also explain how meal timing and specific foods, like fiber, ginger, saturated fat, and various oils, affect sleep onset, sleep quality, and metabolism. Throughout the conversation, we discuss specific foods and diets that directly support weight loss, better sleep, and long-term cardiometabolic health. Comment HUNGER & I’ll DM you a link to the full episode. You can also find the episode by going to Hubermanlab on any of the major podcast platforms: @spotifypodcasts @applepodcasts etc Please put any questions you might have in the comments section below this post and as always, thank you for your interest in science! @stanford @stanford.med #neuroscience #science #ciencia #neurociencia”

All six claims are scientifically supported by published human and preclinical evidence. The mechanistic chain—sleep restriction increases ghrelin and reduces GLP-1, leading to increased hunger and caloric intake in women—is grounded in peer-reviewed endocrinology, sleep medicine, and behavioral nutrition literature. The specific 300-calorie increase figure aligns with documented effect sizes from controlled human feeding studies. No contradictions or significant overstatements were identified.

“Peptides: The Science, Uses & Safety | Dr. Abud Bakri”

The strongest evidence supports BPC-157's direct effects on growth hormone receptor expression in tendon cells (rat in-vitro study, PMID: 25415472). GLP-1's role in increasing growth hormone is supported in both mouse models and a small human study. However, the broader claim of a deliberate peptide 'trinity stack' achieving rapid fitness/health outcomes lacks any human evidence, and BPC-157's 'long history of human use' is overstated—it has minimal clinical trial data (one retrospective case series of 12 patients) and is not FDA-approved. The Russian peptide claims (epithelen, pinealin) and GHK-Cu's aesthetic benefits have no indexed evidence. Preclinical support for individual pathways is real, but human efficacy and safety for the specific stacking protocol described are unproven.

“Comment PROGRAM & I’ll DM you a link to the episode. PRIORITIZE TRAINING TO GET THE BEST HEALTH & BODY RECOMPOSITION RESULTS • My guest on the Huberman Lab podcast out today is Dr Rhonda Patrick @foundmyfitness and she provides a masterclass in science based exercise, nutrition and supplementation protocols, and much more. We go into specifics about her routines and the rationale behind them and for every topic such as omega-3’s, etc we discuss options for sourcing, how the published data compare to her experience and recommendations… and we aexplore the lesser known things that Rhonda is doing now for her health that you may want to consider. We also talk about synergy between protocols that can greatly improve health outcomes. We are all time limited so the opportunity to get more out of combining the right things without spending more time is immensely valuable. Here Rhonda is describing how yes, consuming enough protein is important but that not everyone needs 1 g/ pound of bodyweight and how protein appetite will often vary with training type and intensity. We also covered gut health, why she takes glutamine and creatine, and we cover supplements for mitochondrial health, peptides, plastics, and the rest. Thanks to Rhonda it’s a masterclass and how to customize your health protocols to meet your specific needs, time, constraints, and budget. Comment PROGRAM and I’ll DM you the episode or simply go to hubermanlab.com where it’s linked to all podcast formats. And thank you for your interest in science! @stanford @stanford.med @foundmyfitness #neuroscience #science #neurociencia #health #train”

The claim that a podcast will cover peptides is supported by the robust and extensive scientific literature on peptide research. Peptides are a well-recognized subject across multiple domains (pharmaceutical, food science, cosmetics, nutraceuticals) with dozens of peer-reviewed studies documenting their mechanisms and health applications. This is a straightforward, factually accurate statement about the topic's scientific validity and relevance.

“Benefits & Risks of Peptide Therapeutics for Physical & Mental Health”

Five of six claims are well-supported by credible scientific evidence. GLP-1 agonists, insulin, oxytocin, and BPC-157's roles in their respective domains are grounded in human trials or robust preclinical consensus. Sermorelin's mechanism and clinical use are real, but the FDA indication claim is slightly overstated—sermorelin treats growth hormone deficiency (in which short stature is a symptom), not short stature as an independent indication. No claims are actively contradicted by the evidence; the evidence tier varies appropriately (human trials for GLP-1; preclinical for BPC-157; foundational biochemistry for insulin and oxytocin).